William C Manning, Jr

Title: Innovations of William C. Manning, Jr. in Lung Cancer Detection

Introduction

William C. Manning, Jr., based in Redwood City, California, is an accomplished inventor recognized for his significant contributions to the field of medical diagnostics. With a focus on innovations aimed at improving the detection of lung cancer, Manning holds three patents that exemplify his expertise in utilizing biofluid samples to identify disease states.

Latest Patents

Manning's latest inventions include cutting-edge methods for processing biofluid samples and discovering lung biomarkers. One of his patents details sophisticated methods and compositions for processing biofluid samples, emphasizing the use of nanoparticles to adsorb proteins from samples obtained from subjects with disease states, such as lung cancer. Additionally, his work on lung biomarkers outlines classifiers built on these biomarkers, which aid in determining whether a sample indicates a healthy state, disease state, or comorbidity through advanced data set analysis of protein information.

Career Highlights

Throughout his career, Manning has been affiliated with notable organizations such as Prognomiq, Inc. and the University of California, where he has contributed to groundbreaking research and development. His work demonstrates a commitment to enhancing diagnostic methods that ultimately aim to improve patient outcomes in oncology.

Collaborations

Manning has collaborated with esteemed colleagues, including John E. Blume and Gregory Troiano. Together, they have advanced the understanding of biomarkers in disease detection, showcasing the power of teamwork in achieving innovative breakthroughs in medical diagnostics.

Conclusion

William C. Manning, Jr.'s innovative work has the potential to revolutionize the detection and classification of lung cancer, contributing to vital advancements in the medical field. His patents reflect a dedication to improving healthcare through scientific discovery and technological innovation.